FATP1-IN-1

Research use only, not for human use.

FATP1-IN-1 is a potent inhibitor of fatty acid transport protein 1 (FATP1). It effectively inhibits the activity of recombinant human or mouse acyl-CoA synthetase, which is essential for the function of FATP1.

FATP1-IN-1 (compound 5k) is a fatty acid transport protein 1 (FATP1) inhibitor. FATP1-IN-1 is an inhibition of recombinant human or mouse acyl-CoA synthetase activity of FATP1, with the IC50 values of 0.046 μM or 0.60 μM, respectively.

——

FATP1-IN-1 (p.o.; 10 mg/kg) treatment shows the Cmax, AUC and Tmax were 5.5 μg/mL, 36 μg h/mL and 0.33 hours, respectively, and exceeds the mouse IC50 value of 0.22 μM without considering plasma protein binding.Animal Model:Mouse plasma Dosage:10 mg/kg Administration:P.o.Result:The Cmax, AUC and Tmax were 5.5 μg/mL, 36 μg h/mL and 0.33 hours, respectively.

——

Others

Other Targets

Others

——

——

1431945-95-7

375.46

C18H22FN5OS

>98% (HPLC)

In Vitro:?DMSO : 62.5 mg/mL (166.46 mM; Ultrasonic )

Fc1ccc(nc1)N1CCN(CC(=O)Nc2nc3CCCCc3s2)CC1

——

(-20℃)

With Ice Pack

≥ 2 years